An 8-Week, Randomized, Double-Blind, Placebo-Controlled Trial of Seroquel SR [sustained release quetiapine] Co-Administration for SSRI [Selective Serotonin Reuptake Inhibitor]-Resistant, Comorbid Panic Disorder.
Phase of Trial: Phase IV
Latest Information Update: 27 Jan 2016
At a glance
- Drugs Quetiapine (Primary)
- Indications Panic disorder
- Focus Therapeutic Use
- 03 Jul 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 03 Jul 2012 Actual end date (Dec 2011) added as reported by ClinicalTrials.gov.
- 03 Jul 2012 Actual patient number is 26 according to ClinicalTrials.gov.